About MedicexumFounder profile

Senior regulatory and quality leadership — built inside the industries we now advise.

W. Blaney — founder, Medicexum
UK · MHRA · FSAGMP / GDP
Founder · Responsible Person (GDP)
W. Blaney
Profile

Consultant to blue-chip pharma. Former global quality lead at a FTSE 100 consumer business.

Senior regulatory and quality leader and trained Responsible Person (GDP) whose career spans consulting for blue-chip pharmaceutical multinationals and leading global quality operations for a FTSE 100 consumer goods business. Deep hands-on experience across medicinal cannabis supply chains, controlled drug compliance, GMP/GDP-regulated operations and CBD novel foods — covering licensing strategy, quality system design, supplier qualification, technical due diligence and operational delivery.

Trusted by founders, boards and investors to bring structure, reduce delivery risk and move complex programmes forward — including market entry, international supply chain build, scale-up, turnaround and restructuring. Works selectively with compliance-focused founders building businesses designed to withstand regulatory scrutiny from day one. Strong at bridging regulators, technical teams, manufacturers and commercial stakeholders to convert strategy into executable, compliant plans.

Medicinal CannabisControlled DrugsCBD Novel FoodsPharmaceutical ManufacturingConsumer HealthcareFTSE 100 Quality Ops
01Career
0+
Years in regulated industries
02Track record
0+
Compliance programmes delivered
03Industry
FTSE 0100
Global quality leadership
04Network
0
EU GMP partner producers
Capabilities

Where we add the most value to founders and boards.

01

Regulatory & Quality Systems

GMP / GDP system design, controlled drug compliance, Responsible Person frameworks and licensing strategy.
02

Medicinal Cannabis & CBD

End-to-end cannabis supply chains, CBMP licensing and FSA Novel Foods dossiers for CBD brands.
03

International Supply Chain

EU GMP sourcing, importation routes and supplier qualification for scaled, audit-ready operations.
04

Boards, Founders & Investors

Technical due diligence, turnaround, restructuring and credible regulatory narratives for capital.
Engage

For compliance-focused founders building businesses designed to withstand scrutiny.